48 related articles for article (PubMed ID: 7684020)
1. Comparative immunohistochemical studies of p53 and proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions in pancreatic duct cell carcinomas.
Suzuki T; Takano Y
Jpn J Cancer Res; 1993 Oct; 84(10):1072-7. PubMed ID: 7901190
[TBL] [Abstract][Full Text] [Related]
2. Comparative Analysis of Cluster of Differentiation 57 and Proliferating Cell Nuclear Antigen Expression in Different Grades of Oral Squamous Cell Carcinoma: An Immunohistochemical Study.
Cs AS; Joseph TI; Girish KL; T P; Binu A; Mary J
Cureus; 2023 Sep; 15(9):e44779. PubMed ID: 37809121
[TBL] [Abstract][Full Text] [Related]
3. Expression of Apoptosis Related and Proliferative Proteins in Malignant Lympho-Proliferative Disorders.
Jairajpuri ZS; Ghai R; Saluja S; Kapur S; Bhowmik KT
Iran J Pathol; 2017; 12(3):231-240. PubMed ID: 29531548
[TBL] [Abstract][Full Text] [Related]
4. Association of Proliferative Indices With Various Grades of Breast Carcinoma.
Awasthi S; Gupta P; Mittal A
Cureus; 2023 Jul; 15(7):e41865. PubMed ID: 37583729
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical Expression of Cell Proliferating Nuclear Antigen (PCNA) and p53 Protein in Cervical Cancer.
Madhumati G; Kavita S; Anju M; Uma S; Raj M
J Obstet Gynaecol India; 2012 Oct; 62(5):557-61. PubMed ID: 24082558
[TBL] [Abstract][Full Text] [Related]
6. Expression of heat shock protein 27 and proliferating cell nuclear antigen in human retinoblastoma.
Qin D; Tan L; You Q; Liu X
Contemp Oncol (Pozn); 2013; 17(2):144-9. PubMed ID: 23788981
[TBL] [Abstract][Full Text] [Related]
7. Role of proliferative markers in assessing recurrences in surgical margins of oral squamous cell carcinoma: A systematic review.
Gawande M; Khan S; Sharma N; Hande A; Patil S
J Oral Maxillofac Pathol; 2023; 27(4):735-743. PubMed ID: 38304496
[TBL] [Abstract][Full Text] [Related]
8. Transformation of mouse T cells requires MYC and AKT activity in conjunction with inhibition of intrinsic apoptosis.
Högstrand K; Darmanin S; Forshell TP; Grandien A
Oncotarget; 2018 Apr; 9(30):21396-21410. PubMed ID: 29765548
[TBL] [Abstract][Full Text] [Related]
9. Endocrine, Stemness, Proliferative, and Proteolytic Properties of Alarm Cells in Ruby-Red-Fin Shark (Rainbow Shark),
Abd-Elhafeez HH; Soliman SA; Attaai AH; Abdel-Hakeem SS; El-Sayed AM; Abou-Elhamd AS
Microsc Microanal; 2021 Aug; ():1-14. PubMed ID: 34344492
[TBL] [Abstract][Full Text] [Related]
10. US Air Force to study nuclear missile base lymphomas.
Furlow B
Lancet Oncol; 2023 Apr; 24(4):316. PubMed ID: 36871564
[No Abstract] [Full Text] [Related]
11. Effects of targeting sumoylation processes during latent and induced Epstein-Barr virus infections using the small molecule inhibitor ML-792.
Garcia P; Harrod A; Jha S; Jenkins J; Barnhill A; Lee H; Thompson M; Williams JP; Barefield J; Mckinnon A; Suarez P; Shah A; Lowrey AJ; Bentz GL
Antiviral Res; 2021 Apr; 188():105038. PubMed ID: 33577806
[TBL] [Abstract][Full Text] [Related]
12. TAF Family Proteins and MEF2C Are Essential for Epstein-Barr Virus Super-Enhancer Activity.
Wang C; Jiang S; Zhang L; Li D; Liang J; Narita Y; Hou I; Zhong Q; Gewurz BE; Teng M; Zhao B
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167905
[TBL] [Abstract][Full Text] [Related]
13. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.
Faumont N; Durand-Panteix S; Schlee M; Grömminger S; Schuhmacher M; Hölzel M; Laux G; Mailhammer R; Rosenwald A; Staudt LM; Bornkamm GW; Feuillard J
J Virol; 2009 May; 83(10):5014-27. PubMed ID: 19264782
[TBL] [Abstract][Full Text] [Related]
14. Nucleoli and AgNORs in Hodgkin's disease.
Mamaev NN; Medvedeva NV; Shust VF; Markochev AB; Pasternak ND
Mol Pathol; 1997 Jun; 50(3):149-52. PubMed ID: 9292150
[TBL] [Abstract][Full Text] [Related]
15. Tumor proliferative activity and response to first-line chemotherapy in advanced breast carcinoma.
Bonetti A; Zaninelli M; Rodella S; Molino A; Sperotto L; Piubello Q; Bonetti F; Nortilli R; Turazza M; Cetto GL
Breast Cancer Res Treat; 1996; 38(3):289-97. PubMed ID: 8739082
[TBL] [Abstract][Full Text] [Related]
16. Argyrophilic nucleolar organizer regions. A revised version of the Ag-NOR-staining technique.
Li Q; Hacker GW; Danscher G; Sonnleitner-Wittauer U; Grimelius L
Histochem Cell Biol; 1995 Aug; 104(2):145-50. PubMed ID: 8536071
[TBL] [Abstract][Full Text] [Related]
17. p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas.
Korkolopoulou P; Oates J; Kittas C; Crocker J
J Clin Pathol; 1994 Jan; 47(1):9-14. PubMed ID: 7907610
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow tissue and proliferation markers: results and general problems.
Thiele J; Fischer R
Virchows Arch A Pathol Anat Histopathol; 1993; 423(6):409-16. PubMed ID: 7904783
[No Abstract] [Full Text] [Related]
19. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
